Penumbra (PEN) Shares Outstanding (Diluted Average) (2014 - 2026)
Penumbra (PEN) reported Shares Outstanding (Diluted Average) of $39.5 million for Q1 2026, up 0.97% year-over-year from $39.2 million in Q1 2025, and up 0.64% on a QoQ basis from $39.3 million in Q4 2025.
Penumbra (PEN) has 13 years of Shares Outstanding (Diluted Average) data on file, last reported at $39.5 million in Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) rose 0.97% year-over-year to $39.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.5 million (up 0.97% YoY) and the FY2025 annual result came in at $39.3 million, changed 0.06% from the prior year.
- Shares Outstanding (Diluted Average) grew to $39.5 million in Q1 2026 per PEN's latest filing, from $39.3 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $39.5 million in Q1 2026 and bottomed at $37.8 million in Q2 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $39.2 million (2025), against an average of $38.9 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) grew 3.66%; it then retreated 1.22% in 2024.
- Tracing PEN's Shares Outstanding (Diluted Average) over 5 years: stood at $37.8 million in 2022, then increased by 3.63% to $39.2 million in 2023, then gained by 0.13% to $39.3 million in 2024, then climbed by 0.06% to $39.3 million in 2025, then advanced by 0.64% to $39.5 million in 2026.
- Per Business Quant, the three latest PEN Shares Outstanding (Diluted Average) figures stand at $39.5 million (Q1 2026), $39.3 million (Q4 2025), and $39.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 39.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.54 Mn |
| Dec 31, 2025 | 39.29 Mn |
| Sep 30, 2025 | 39.25 Mn |
| Jun 30, 2025 | 39.25 Mn |
| Mar 31, 2025 | 39.16 Mn |
| Dec 31, 2024 | 39.27 Mn |
| Sep 30, 2024 | 38.71 Mn |
| Jun 30, 2024 | 38.79 Mn |
| Mar 31, 2024 | 39.39 Mn |
| Dec 31, 2023 | 39.22 Mn |
| Sep 30, 2023 | 39.18 Mn |
| Jun 30, 2023 | 39.15 Mn |
| Mar 31, 2023 | 39.08 Mn |
| Dec 31, 2022 | 37.84 Mn |
| Sep 30, 2022 | 37.92 Mn |
| Jun 30, 2022 | 37.77 Mn |
| Mar 31, 2022 | 38.71 Mn |
| Dec 31, 2021 | 37.88 Mn |
| Sep 30, 2021 | 37.61 Mn |
| Jun 30, 2021 | 37.58 Mn |
| Mar 31, 2021 | 37.53 Mn |
| Dec 31, 2020 | 35.77 Mn |
| Sep 30, 2020 | 36.21 Mn |
| Jun 30, 2020 | 35.40 Mn |
| Mar 31, 2020 | 36.36 Mn |
| Dec 31, 2019 | 36.27 Mn |
| Sep 30, 2019 | 36.27 Mn |
| Jun 30, 2019 | 36.21 Mn |
| Mar 31, 2019 | 36.21 Mn |
| Dec 31, 2018 | 36.09 Mn |
| Sep 30, 2018 | 34.25 Mn |
| Jun 30, 2018 | 36.12 Mn |
| Mar 31, 2018 | 35.92 Mn |
| Dec 31, 2017 | 35.32 Mn |
| Sep 30, 2017 | 35.66 Mn |
| Jun 30, 2017 | 33.22 Mn |
| Mar 31, 2017 | 31.61 Mn |
| Dec 31, 2016 | 33.48 Mn |
| Sep 30, 2016 | 33.76 Mn |
| Jun 30, 2016 | 33.31 Mn |
| Mar 31, 2016 | 33.02 Mn |
| Dec 31, 2015 | 14.22 Mn |
| Sep 30, 2015 | 10.19 Mn |
| Jun 30, 2015 | 5.10 Mn |
| Mar 31, 2015 | 7.19 Mn |
| Dec 31, 2014 | 4.61 Mn |
| Sep 30, 2014 | 4.69 Mn |
| Jun 30, 2014 | 6.87 Mn |
| Mar 31, 2014 | 6.71 Mn |